| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| kras g12d clinical trials | 0.31 | 0.7 | 264 | 96 | 25 |
| kras | 0.07 | 0.1 | 1224 | 16 | 4 |
| g12d | 1.29 | 0.1 | 9622 | 10 | 4 |
| clinical | 0.26 | 0.9 | 7705 | 44 | 8 |
| trials | 1.46 | 0.4 | 1100 | 19 | 6 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| kras g12d clinical trials | 1.86 | 0.9 | 8798 | 78 |
| kras g12d mutation clinical trials | 0.82 | 0.5 | 5488 | 36 |
| kras g12d mrtx1133 clinical trials | 1.1 | 0.8 | 580 | 58 |
| kras g12d inhibitor clinical trial | 0.12 | 0.5 | 4399 | 10 |
| kras g12c inhibitor clinical trial | 1.93 | 0.2 | 5876 | 65 |
| kras g12d targeted therapy | 1.08 | 0.9 | 6647 | 28 |
| kras g12d lung cancer | 1.38 | 0.7 | 3102 | 59 |
| kras g12d mutation and treatment | 0.76 | 0.1 | 40 | 44 |
| what is kras g12d | 0.26 | 0.1 | 2487 | 27 |
| kras g12v pancreatic cancer trials | 0.47 | 0.8 | 3723 | 2 |
| kras g12d colorectal cancer | 0.27 | 0.9 | 6485 | 60 |
| kras g12d cell line | 0.3 | 0.3 | 5301 | 24 |
| kras g12d recombinant protein | 1.11 | 1 | 9252 | 40 |
| kras g12d pancreatic cancer | 1.36 | 0.3 | 4200 | 96 |
| kras g12d colon cancer | 1.57 | 0.3 | 7181 | 77 |
| kras g12d colon cancer treatment | 0.69 | 0.4 | 5364 | 21 |
| kras g12c inhibitor fda approval | 1.24 | 0.9 | 3979 | 70 |
| kras g12c lung cancer | 0.2 | 0.5 | 5753 | 32 |
